Nederlands
English
About VIB
Currently selected
Science communication
Home
>
About VIB
>
Press
Refine
Theme
About VIB (92)
Arabidopsis (3)
Bioinformatics (11)
Biotech basics (1)
Cancer (69)
Cardiovascular medicine (11)
Cell biology (9)
Grand Challenges (4)
Immunology (32)
Inflammation and immunity (55)
Microbiology (23)
Model Organisms (4)
Mouse (2)
Neuroscience (59)
Plant biology (41)
Proteomics (5)
Research Areas (3)
Science ethics (2)
Structural biology (17)
Systems biology (2)
Yeast (1)
Category
BioInformatics Training and Service facility (1)
Business opportunities (8)
Developmental biology (1)
Event (8)
News (34)
Research services (5)
Page Content Zone 1
Press
Receive VIB press releases
Email updates
Follow us on Twitter
Like us on Facebook
RSS
Contact
For all press inquiries, contact
Katrina Wright
Tel.: +32 9 244 66 11
Recent press releases
Tau prevents synaptic transmission at early stage of neurodegeneration
19 May 2017
Prof. Patrik Verstreken’s research team (VIB-KU Leuven) has now discovered how tau disrupts the functioning of nerve cells, even before it starts forming tangles. They immediately suggest a way to intervene in this process.
Helena Biosciences to develop automated blood test for chronic liver disease based on VIB and Ghent University research
16 May 2017
Helena Biosciences announced today that it is commercialising a new blood test for Chronic Liver Disease (CLD) in cooperation with the Ghent University branch of VIB – the life sciences research institute of Flanders, Belgium.
VIB presents its 2016 annual results: a clear creation of added value for society
15 May 2017
VIB presents its results in its 2016 annual report. Below is a limited selection of implementations from the past year that will have a significant impact on our society.
Researchers identify nutrient metabolism that drives breast tumor metastasis
11 May 2017
A group of scientists, led by Sarah-Maria Fendt (VIB-KU Leuven), discovered that breast cancer cells that have invaded other organs rely on different nutrient metabolism to produce energy than normal cells and non-metastasizing cancer cells.
Launch of IMPRiND Consortium to investigate how aggregated proteins contribute to progression of Alzheimer’s and Parkinson's Disease
11 May 2017
The Innovative Medicines Initiative launched IMPRiND, an innovative research project that is devoted to investigate whether mechanisms of propagation of aggregated proteins between cells could enable novel therapeutic approaches in Alzheimer’s and PA.
A new role for progranulin, as a cathepsin D chaperone
8 May 2017
In a recent study in Human Molecular Genetics, researchers from VIB and KU Leuven led by prof. Philip Van Damme, reveal a novel function for progranulin in lysosomes: it acts as chaperone of the lysosomal protease cathepsin D.
Scientists gain insights into how Fragile X syndrome disrupts perception
4 May 2017
A collaboration between scientists in Belgium, the US, Norway, France & UK has resulted in a study that sheds light on neural mechanisms of Fragile X syndrome. This genetic disorder causes disruptions in the way neurons transmit information to each other
Crucial role for XBP1 in several aspects of DC functioning and homeostasis
4 May 2017
Type 1 conventional dendritic cells (cDC1s) play a crucial role in orchestrating the balance between protective anti-viral or anti-tumour immunity and tolerance to self-antigens.
A new unexpected key player in melanoma development identified
3 May 2017
Rsearchers from VIB, KU Leuven together with colleagues from INSERM report the important role for FES in the initiation and progression of melanoma that is notoriously quick to metastasize and that responds poorly to existing cancer treatments.
Lipidomics paves the way to groundbreaking scientific discoveries
25 April 2017
By expanding VIB’s network of technology suppliers, purchasing licenses and negotiating business partnerships, the Tech Watch team enables VIB scientists to have privileged access to cutting-edge scientific innovations.
Metastatic breast cancers: Characterising the profile of metastases for improved treatment
24 April 2017
Researchers at the Jules Bordet Institute, ULB, VIB and KU Leuven published a study offering a better understanding of the progression of breast cancer. The conclusions could have an impact on care for patients suffering from a metastatic breast cancer
Speaking up for animal research
22 April 2017
Young researchers from within and outside of VIB got founded ‘Infopunt Proefdieronderzoek’ (Dutch for Animal Research Info Point). Through a web platform and social media presence, they aim to provide up-to-date and clear information on animal research.
The Baillet Latour Grant 2017 for Medical Research awarded to professor Roosmarijn Vandenbroucke (VIB-UGent)
20 April 2017
This year the Grant is awarded to Professor Roosmarijn Vandenbroucke for her research project in the field of neurological diseases. Delivery of therapeutics into the brain to treat neurological diseases remains a major, unsolved challenge.
Multiplexing CRISPR: thousands of mutations, endless possibilities for discovery
15 April 2017
While basic CRISPR experiments are already transforming life sciences research, there are many emerging CRISPR tools that open up previously unimaginable opportunities.
Specialized blood vessels enhance tumor-fighting immunotherapy
12 April 2017
Scientists from VIB and KU Leuven, together with colleagues from the University of California and the Swiss Institute for Experimental Cancer Research have demonstrated that , anti-angiogenic therapy can improve immune boosting treatments.
«Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
Next»
Page Content Zone 2
Page Content Zone 3